Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.
about
Current and emerging treatment options for uveal melanoma.Long-term survivors with metastatic uveal melanoma.Grb2-associated binder 2 expression and its roles in uveal melanoma invasion.c-FLIP and the NOXA/Mcl-1 axis participate in the synergistic effect of pemetrexed plus cisplatin in human choroidal melanoma cells.
P2860
Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.
@en
Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.
@nl
type
label
Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.
@en
Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.
@nl
prefLabel
Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.
@en
Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.
@nl
P2093
P2860
P1476
Quality of evidence about effectiveness of treatments for metastatic uveal melanoma
@en
P2093
Adeel H Shaikh
James J Augsburger
Zélia M Corrêa
P2860
P304
128-35; discussion 135-7
P577
2008-01-01T00:00:00Z